Literature DB >> 6583377

Nude mouse xenograft study for treatment of neuroblastoma: effects of chemotherapeutic agents and surgery on tumor growth and cell kinetics.

Y Tsuchida, K Yokomori, T Iwanaka, S Saito.   

Abstract

Four human neuroblastomas transplanted into nude mice were used for experimental chemotherapy and surgery, and the following results were obtained. Cyclophosphamide was the most effective for human neuroblastoma, cis-platinum being the second, among several chemotherapeutic drugs examined. Aclacinomycin A is more effective than Adriamycin. VM26 should be administered 48 to 72 hours after injection of cis-platinum, according to flow cytometric analysis. Flow cytometric analysis also disclosed that residual tumor grows most rapidly seven days after subtotal excision. However, chemotherapy is more effective in the postoperative period than it is in the preoperative period.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6583377     DOI: 10.1016/s0022-3468(84)80020-2

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

1.  Characterization of N-myc amplification in a human neuroblastoma cell line by clones isolated following the phenol emulsion reassociation technique and by hexagonal field gel electrophoresis.

Authors:  Y Nishi; K Akiyama; B R Korf
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy.

Authors:  Alvin Kamili; Andrew J Gifford; Nancy Li; Chelsea Mayoh; Shu-Oi Chow; Timothy W Failes; Georgina L Eden; Roxanne Cadiz; Jinhan Xie; Robyn E Lukeis; Murray D Norris; Michelle Haber; Geoffrey B McCowage; Greg M Arndt; Toby N Trahair; Jamie I Fletcher
Journal:  Br J Cancer       Date:  2020-01-10       Impact factor: 7.640

Review 3.  The Promise of Patient-Derived Preclinical Models to Accelerate the Implementation of Personalised Medicine for Children with Neuroblastoma.

Authors:  Elizabeth R Tucker; Sally George; Paola Angelini; Alejandra Bruna; Louis Chesler
Journal:  J Pers Med       Date:  2021-03-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.